Base Year
Historical Year
Forecast Year
The global anaemia drugs market is expected to grow at a CAGR of 8% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market growth of anaemia drugs is being driven by the significant contribution by North America to the global market. This could be attributed to the increase in incidence of the condition, increase in kidney diseases, and unhealthy lifestyle across the region. In addition, rise in health care expenditure, high research activities, advanced technology, and increasing awareness about anaemia are predicted to bolster the anaemia drugs industry in the region. Europe is expected to follow North America, in terms of contribution to the overall market growth. The market in the Asia Pacific is predicted to grow rapidly over the forecast period as the result of rising healthcare expenditure, surge in disposable income, rise in geriatric population, increase in awareness, high prevalence of chronic diseases, and complications during pregnancy in many developing countries.
Anaemia is a medical condition in which red blood cell (RBC) count or haemoglobin is less than normal. Anaemia results in shortness of breath, fatigue, palpitations, and dizziness. Anaemic drugs are used in the treatment of this condition.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of anaemia type, the market is divided into:
Based on drugs, the industry can be segmented into:
The dietary supplements are further divided on the basis of types into iron supplements and vitamin supplements, among others, whereas medicines are further divided into antibiotics, hormones (erythropoietin), chelation therapy (lead poisoning), among others.
By distribution channel, the industry is categorised into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market growth of anaemia drugs is being driven by the rising prevalence of this condition in children and women. In addition, factors such as unhealthy lifestyle, high number of women of reproductive age, development of pipeline products, and complications during pregnancy, especially in developing countries are expected to provide impetus over the forecast period. Further, rise in geriatric population, enhancing healthcare infrastructure, and rapid R&D are expected to fuel the market growth over the forecast period. However, factors like lack of awareness about health in many developing countries and expensive drugs are anticipated to hinder the market growth of anaemia drugs over the forecast period.
The report gives a detailed analysis of the following key players in the global anaemia drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Anaemia Type |
|
| Breakup by Drugs |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is projected to grow at a CAGR of 8% between 2024 and 2032.
The major drivers of the market include rising prevalence of anaemia and increasing geriatric population.
The key trends guiding the growth of the market include the enhancing healthcare infrastructure and rapid research and development.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading anaemia types in the market report are iron deficiency, CKD (chronic kidney disease), sickle cell, and aplastic, among others.
The major drugs in the market are dietary supplements and medicines.
The significant distribution channels in the market are hospital pharmacy, store pharmacy, and online, among others.
The major players in the global anaemia drugs market are Amgen Inc., Pieris Pharmaceuticals, Inc., Pfizer Inc., Akebia Therapeutics, Inc., and Takeda Pharmaceutical Company Limited, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share